DMAC's logo.
Ticker Symbol: DMAC

DiaMedica Therapeutics Inc

$4.05 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001401040

Company Profile

DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments to improve the lives of patients with neurological and chronic kidney diseases.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
CEO: N/A
Tags:
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $2.31
Change: -$0.17 ( -6.83%)
Days Range: $2.22 - $2.50
Beta: 0.63
52wk. High: $4.75
52wk. Low: $1.12
Ytd. Change 50.76%
50 Day Moving Average: $2.70
200 Day Moving Average: $2.77
Shares Outstanding: 37949422

Valuation

Market Cap: 8.8B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A